Search for other papers by Liza Haqq in
Google Scholar
PubMed
Search for other papers by James McFarlane in
Google Scholar
PubMed
Search for other papers by Gudrun Dieberg in
Google Scholar
PubMed
Search for other papers by Neil Smart in
Google Scholar
PubMed
final analysis (see consort statement, Fig. 1 ). Figure 1 Consort statement. Data synthesis and outcome measures Our lifestyle intervention groups were defined as exercise-alone or exercise-plus-diet groups. Our definition of usual care (comparator
Search for other papers by Thomas Reinehr in
Google Scholar
PubMed
Search for other papers by Alexandra Kulle in
Google Scholar
PubMed
Search for other papers by Juliane Rothermel in
Google Scholar
PubMed
Search for other papers by Caroline Knop-Schmenn in
Google Scholar
PubMed
Search for other papers by Nina Lass in
Google Scholar
PubMed
Search for other papers by Christina Bosse in
Google Scholar
PubMed
Search for other papers by Paul-Martin Holterhus in
Google Scholar
PubMed
using an LC–MS/MS steroid profiling method ( 7 ) in obese adolescent girls with PCOS participating in a lifestyle intervention. Subjects and methods The Local Ethics Committee of the University of Witten/Herdecke approved this study. Written
Search for other papers by Thomas Reinehr in
Google Scholar
PubMed
Search for other papers by Alberto Sánchez-Guijo in
Google Scholar
PubMed
Search for other papers by Nina Lass in
Google Scholar
PubMed
Search for other papers by Stefan A Wudy in
Google Scholar
PubMed
normalized hormones like leptin, cortisol or adiponectin ( 6 , 22 , 23 , 24 ). All children participated in the lifestyle intervention ‘Obeldicks’, which has been described in detail elsewhere ( 25 ). Briefly, this outpatient intervention program for
Comprehensive Heart Failure Center, University & University Hospital Würzburg, Würzburg, Germany
Search for other papers by Ann-Cathrin Koschker in
Google Scholar
PubMed
Department of Psychiatry, Psychosomatics and Psychotherapy, University Hospital, University of Würzburg, Würzburg, Germany
Search for other papers by Bodo Warrings in
Google Scholar
PubMed
Division of Cardiology, Department of Internal Medicine I, University Hospital, University of Würzburg, Würzburg, Germany
Search for other papers by Caroline Morbach in
Google Scholar
PubMed
Search for other papers by Florian Seyfried in
Google Scholar
PubMed
Search for other papers by Nicole Rickert in
Google Scholar
PubMed
Search for other papers by Pius Jung in
Google Scholar
PubMed
Search for other papers by Andreas Geier in
Google Scholar
PubMed
Search for other papers by Ulrich Dischinger in
Google Scholar
PubMed
Search for other papers by Maike Krauthausen in
Google Scholar
PubMed
Search for other papers by Martin J Herrmann in
Google Scholar
PubMed
Department of General, Visceral, Transplant, Vascular, and Pediatric Surgery, University Hospital, University of Würzburg, Würzburg, Germany
Search for other papers by Christine Stier in
Google Scholar
PubMed
Division of Cardiology, Department of Internal Medicine I, University Hospital, University of Würzburg, Würzburg, Germany
Search for other papers by Stefan Frantz in
Google Scholar
PubMed
Search for other papers by Uwe Malzahn in
Google Scholar
PubMed
Division of Cardiology, Department of Internal Medicine I, University Hospital, University of Würzburg, Würzburg, Germany
Search for other papers by Stefan Störk in
Google Scholar
PubMed
Comprehensive Heart Failure Center, University & University Hospital Würzburg, Würzburg, Germany
Search for other papers by Martin Fassnacht in
Google Scholar
PubMed
Search for other papers by the WAS Study Group in
Google Scholar
PubMed
, 15 ). Lifestyle intervention was not able to reduce the rate of cardiovascular events in obese patients with type 2 diabetes ( 16 ), but mortality might be reduced by bariatric surgery ( 11 , 17 ). Large Swedish registries found that obese patients
Department of Pediatrics, The Second Affiliated Hospital of Nanjing Medical University, Nanjing, China
Search for other papers by Anru Wang in
Google Scholar
PubMed
Search for other papers by Xueqin Yan in
Google Scholar
PubMed
Search for other papers by Cai Zhang in
Google Scholar
PubMed
Search for other papers by Caiqi Du in
Google Scholar
PubMed
Search for other papers by Wenjun Long in
Google Scholar
PubMed
Search for other papers by Di Zhan in
Google Scholar
PubMed
Search for other papers by Xiaoping Luo in
Google Scholar
PubMed
non-IR group ( n = 26). Obese children and adolescents whose weight change more than 5% after 6 months of lifestyle intervention were included in subsequent studies. Those individuals treated with medications or weight loss less than 5% were
Search for other papers by Johan Verhelst in
Google Scholar
PubMed
Search for other papers by Anders F Mattsson in
Google Scholar
PubMed
Search for other papers by Cecilia Camacho-Hübner in
Google Scholar
PubMed
Search for other papers by Anton Luger in
Google Scholar
PubMed
Search for other papers by Roger Abs in
Google Scholar
PubMed
normality independently of any condition. The other one, metabolic disruption, could be prevented by timely diagnosis of GHD and treated by adequate GH replacement, but it will also require a lifestyle intervention, physical activity and especially weight
Search for other papers by Alexis Sudlow in
Google Scholar
PubMed
Search for other papers by Carel W le Roux in
Google Scholar
PubMed
Search for other papers by Dimitri J Pournaras in
Google Scholar
PubMed
Bariatric surgery is established as a highly effective treatment for obesity and related metabolic complications. Although once seen as a last resort for patients with obesity, given the data demonstrating the profound weight loss, improvement in comorbidity and safety, perceptions have since shifted. There is evidence from 12 RCTs demonstrating its safety and efficacy in terms of weight loss which is sustained in the long term with a resultant improvement in co-morbidity. Clinicians are increasingly recognising the importance of timely intervention to maximise the effects of bariatric surgery, particularly in light of the low likelihood of being able to adequately manage patients with medication or lifestyle interventions alone. The inclusion of bariatric surgery in the standard treatment algorithm has been a step forward in the approach to treating patients with obesity. What remains challenging for clinicians is knowing which procedure is most beneficial to patients. There is no level one data demonstrating the superiority of one procedure over another. Head to head RCTs are ongoing which may shed light on this question; however, it is likely that there is no single procedure that will be demonstrated to be the gold standard. Herein we review the most commonly performed procedures along with the evidence available to support their effects with regards to weight loss and metabolic changes along with their limitations and recognised risks. The aim is to provide a general framework to allow clinicians to take advantage of the variety of operative approaches to tailor their treatment strategy to the individual patient.
Search for other papers by Eliana Piantanida in
Google Scholar
PubMed
Search for other papers by Daniela Gallo in
Google Scholar
PubMed
Research Center in Epidemiology and Preventive Medicine (EPIMED), University of Insubria, Varese, Italy
Search for other papers by Giovanni Veronesi in
Google Scholar
PubMed
Search for other papers by Eugenia Dozio in
Google Scholar
PubMed
Search for other papers by Eugenia Trotti in
Google Scholar
PubMed
Search for other papers by Adriana Lai in
Google Scholar
PubMed
Search for other papers by Silvia Ippolito in
Google Scholar
PubMed
Search for other papers by Jessica Sabatino in
Google Scholar
PubMed
Search for other papers by Maria Laura Tanda in
Google Scholar
PubMed
Search for other papers by Antonio Toniolo in
Google Scholar
PubMed
Research Center in Epidemiology and Preventive Medicine (EPIMED), University of Insubria, Varese, Italy
Search for other papers by Marco Ferrario in
Google Scholar
PubMed
Search for other papers by Luigi Bartalena in
Google Scholar
PubMed
.4 release (SAS Institute Inc., Cary, NC, USA). Results In the study period, a cohort of 196 obese adults (152 women, 51 ± 13 years) fulfilled the inclusion criteria. Fifty-eight percent of patients had never participated in a lifestyle intervention
Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark
Search for other papers by Malin Nylander in
Google Scholar
PubMed
Department of Internal Medicine, Endocrine Unit, Herlev Gentofte Hospital, Herlev, Denmark
Search for other papers by Signe Frøssing in
Google Scholar
PubMed
Department of Internal Medicine, Endocrine Unit, Herlev Gentofte Hospital, Herlev, Denmark
Search for other papers by Caroline Kistorp in
Google Scholar
PubMed
Department of Internal Medicine, Endocrine Unit, Herlev Gentofte Hospital, Herlev, Denmark
Search for other papers by Jens Faber in
Google Scholar
PubMed
Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark
Search for other papers by Sven O Skouby in
Google Scholar
PubMed
risk of VTE in PCOS. Lifestyle intervention and metformin are mainstays in the treatment of PCOS, aiming at reducing body weight and insulin resistance. In women with PCOS, metformin has been found to reduce PAI-1 activity and levels of hsCRP to a
Search for other papers by Monika Karczewska-Kupczewska in
Google Scholar
PubMed
Search for other papers by Agnieszka Nikołajuk in
Google Scholar
PubMed
Search for other papers by Radosław Majewski in
Google Scholar
PubMed
Search for other papers by Remigiusz Filarski in
Google Scholar
PubMed
Search for other papers by Magdalena Stefanowicz in
Google Scholar
PubMed
Search for other papers by Natalia Matulewicz in
Google Scholar
PubMed
Search for other papers by Marek Strączkowski in
Google Scholar
PubMed
their insulin sensitivity after the dietary intervention program. Subjects with lower initial insulin sensitivity achieved greater metabolic benefit from lifestyle intervention ( 29 ). Findings similar to ours regarding worsening ( 29 , 30 ), or the